# No1 Biotechnology Company
RESEARCH
BioSage is committed to advancing biotechnology through responsible research, scientific integrity, and innovation. Every product and technology we develop is guided by our dedication to sustainability, public health, and environmental stewardship.
Our Innovation
BioSage has developed a proprietary peptide-based larvicidal technology utilizing genetically engineered bacteria as a biological production platform. The peptide is designed to provide targeted activity against mosquito larvae, offering a promising alternative to conventional chemical larvicides.
Sustainable Vector Management
Supports the development of effective, targeted, and potentially biodegradable tools for mosquito population management
Precision Biological Action
Designed to target biological pathways or structures relevant to mosquito larvae, helping minimize unnecessary effects on non-target organisms.
Engineered Microbial Production
Genetically engineered bacteria are used as a biological platform for the efficient production of the target peptide.
Environmentally Responsible Approach
A peptide-based strategy may offer a more biologically focused alternative to conventional broad-spectrum chemical larvicides.
Targeted Larvicidal Activity
The peptide is specifically designed to act against mosquito larvae, supporting selective and targeted vector control.
Innovative Biotechnology Platform
Combines genetic engineering, recombinant protein production, and vector-control research to develop next-generation larvicidal solutions.
BioSage
Advancing Science. Creating Impact.
We are a biotechnology research company dedicated to developing innovative, science-driven solutions for real-world challenges. Through advanced research,